Your session is about to expire
← Back to Search
Memory Support System for Mild Cognitive Impairment
N/A
Waitlist Available
Led By Neil Thomas, MD
Research Sponsored by Bruyere Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from study start date up to 19 months.
Awards & highlights
Study Summary
This trial is looking into providing patients with MCI and their partners a Memory Support System (MSS) to help with daily tasks, self-efficacy, mood, anxiety, and caregiver burden. It will also measure cost and use of the system.
Who is the study for?
This study is for individuals with mild cognitive impairment who have a care partner they see at least twice a week. They should have certain scores on dementia and cognitive assessments, and not be taking or changing doses of memory drugs for the last 3 months. People can't join if they're in another similar trial or have visual/hearing issues that would affect using the Memory Support System.Check my eligibility
What is being tested?
The study tests how well a Memory Support System works when given to patients with mild cognitive impairment at an Ontario clinic. It looks into patient interest, best ways to deliver the system, costs of implementation, and its impact on daily activities, confidence in memory abilities, life quality, mood, anxiety levels, and caregiver stress.See study design
What are the potential side effects?
Since this trial involves a non-drug intervention (Memory Support System), traditional medication side effects are not expected. However, participants may experience frustration or stress while learning to use the system or due to changes in their routine.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from study start date up to 19 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from study start date up to 19 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Interest in completion of MSS training
Secondary outcome measures
Adherence to French Memory Support System Intervention
Caregiver Burden Inventory Short-Form
Center for Epidemiologic Studies Depression Scale
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Memory Support System participantsExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Memory Support System
2010
N/A
~140
Find a Location
Who is running the clinical trial?
Bruyere Research InstituteLead Sponsor
34 Previous Clinical Trials
2,024,179 Total Patients Enrolled
Ottawa Hospital Research InstituteOTHER
561 Previous Clinical Trials
2,785,651 Total Patients Enrolled
Neil Thomas, MDPrincipal InvestigatorBruyere Research Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with mild cognitive impairment.I have a caregiver who checks on me at least twice a week.I haven't started or changed my brain-enhancing drugs in the last 3 months.
Research Study Groups:
This trial has the following groups:- Group 1: Memory Support System participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available slots to join the clinical trial?
"According to information contained on clinicaltrials.gov, this medical trial is presently not enrolling patients; it was originally posted on September 1st 2023 and last updated August 10th 2023. Though recruitment has ended for this specific study, 624 other trials are currently seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger